PFE Stock Recent News
PFE LATEST HEADLINES
Pfizer's PEG ratio according to one widely used financial website is shockingly low. This low valuation metric raises questions.
Over the last twelve months, Pfizer's stock experienced a massive sell-off due to a massive revenue and EPS drop after the COVID-related spikes of 2021 and 2022. However, the company's financial performance just moderated to its more normal levels and I do not see a disaster here. Pfizer's stock is deeply undervalued and currently offers an attractive 6.3% dividend yield.
Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.
Pfizer's (PFE) RSV vaccine, Abrysvo, generates an immune response in a phase III study evaluating it in higher-risk adults aged 18 to 59, non-inferior to that in older adults.
Drug giant Pfizer has been investing big money into oncology in recent years. In a decade, the company's product mix may look significantly different than today.
A late-stage trial of Pfizer's RSV vaccine showed promising results in adults under 60 years old, suggesting the shot could help people as young as 18, the company announced Tuesday, amid an effort to expand the vaccine's availability to more people who are at a higher risk to the potentially lethal infection.
Pfizer Inc (NYSE PFE) stock is up 1.7% at $27.04 at last check, following news a late-stage trial of its respiratory syncytial virus (RSV) vaccine Abrysvo generated an immune response in higher risk adults under the age of 60.
Pfizer plans to file for an expanded approval of Abrysvo, which is currently approved for adults ages 60 and above and expectant mothers.
Ken Griffin's Citadel hedge fund more than quadrupled its stake in this stock in 2023 Q4. Griffin probably likes the stock because of its valuation, dividend, and surprisingly robust growth prospects.
In the latest trading session, Pfizer (PFE) closed at $26.58, marking a -0.3% move from the previous day.